← Leaderboards
Keith R Johnson
University Of Toledo
$12,330,011
Attributed
$12,330,011
Total exposure
14
Grants
14
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.8M · FY2005–17$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$23,528,707 · 16
By mechanism
P20$9,867,078 · 6
P30$8,261,297 · 4
R01$3,356,999 · 2
P50$897,021 · 1
U54$636,442 · 1
R21$359,370 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Toledo
Same institution · by research overlap
- Mohammad H Elahinia$499,106
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionFundingResearch PersonnelCadherinsCellsGrantCell MotilityNebraskaCenters Of Research ExcellenceMalignant NeoplasmsProgramsDesignCollegeDentistryMentorsMemberUnited States National Institutes Of HealthEpithelial CellsInnovationInstitutesMesenchymalBaseEpithelial To Mesenchymal TransitionStaging
Grant awards (53)
Nebraska Center for Cellular Signaling$943,905
P30 · FY2017 · GM · contact PI
Research Pilot Project Program$376,250
P30 · FY2017 · GM · contact PI
ADMINISTRATIVE CORE$269,703
P30 · FY2017 · GM · contact PI
Nebraska Center for Cellular Signaling$903,905
P30 · FY2016 · GM · contact PI
Research Pilot Project Program$376,250
P30 · FY2016 · GM · contact PI
ADMINISTRATIVE CORE$269,703
P30 · FY2016 · GM · contact PI
Nebraska Center for Cellular Signaling$70,178
P30 · FY2016 · GM · contact PI
Project-001$70,178
P30 · FY2016 · GM · contact PI
Nebraska Center for Cellular Signaling$953,905
P30 · FY2015 · GM · contact PI
Research Pilot Project Program$376,250
P30 · FY2015 · GM · contact PI
ADMINISTRATIVE CORE$269,703
P30 · FY2015 · GM · contact PI
Role of N-Cadherin in Pancreatic Tumor Microenvironment$159,024
U54 · FY2015 · CA · contact PI
Studies on Cadherin/Catenin Complexes$75,250
R03 · FY2015 · CA · contact PI
Nebraska Center for Cellular Signaling$1,028,905
P30 · FY2014 · GM · contact PI
Research Pilot Project Program$376,250
P30 · FY2014 · GM · contact PI
ADMINISTRATIVE CORE$269,703
P30 · FY2014 · GM · contact PI
Role of N-Cadherin in Pancreatic Tumor Microenvironment$159,822
U54 · FY2014 · CA · contact PI
Studies on Cadherin/Catenin Complexes$75,250
R03 · FY2014 · CA · contact PI
Nebraska Center for Cellular Signaling$1,023,905
P30 · FY2013 · GM · contact PI
ADMINISTRATIVE CORE$341,303
P30 · FY2013 · GM · contact PI
Research Pilot Project Program$341,301
P30 · FY2013 · GM · contact PI
Role of N-Cadherin in Pancreatic Tumor Microenvironment$145,162
U54 · FY2013 · CA · contact PI
Nebraska Center for Cellular Signaling$1,958,992
P20 · FY2012 · GM · contact PI
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer$197,835
P50 · FY2012 · CA · contact PI
Role of N-Cadherin in Pancreatic Tumor Microenvironment$172,434
U54 · FY2012 · CA · contact PI
Nebraska Center for Cellular Signaling$1,944,901
P20 · FY2011 · RR · contact PI
COBRE: UNE MED CTR: ADMINISTRATIVE CORE$497,213
P20 · FY2011 · RR · contact PI
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer$157,568
P50 · FY2011 · CA · contact PI
Nebraska Center for Cellular Signaling$1,964,546
P20 · FY2010 · RR · contact PI
COBRE: UNE MED CTR: ADMINISTRATIVE CORE$393,596
P20 · FY2010 · RR · contact PI
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer$201,124
P50 · FY2010 · CA · contact PI
Exploiting Novel Pathways to Treat Pancreatic Cancer$196,020
R21 · FY2010 · CA · contact PI
Nebraska Center for Cellular Signaling$1,964,546
P20 · FY2009 · RR · contact PI
COBRE: UNE MED CTR: ADMINISTRATIVE CORE$510,780
P20 · FY2009 · RR · contact PI
Nebraska Center for Cellular Signaling$400,000
P20 · FY2009 · RR · contact PI
Aspects of Cadherin/Catenin Complexes$356,843
R01 · FY2009 · GM · contact PI
LIVE CELL MICROSCOPY CORE$232,504
P20 · FY2009 · RR · contact PI
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer$200,372
P50 · FY2009 · CA · contact PI
Exploiting Novel Pathways to Treat Pancreatic Cancer$163,350
R21 · FY2009 · CA · contact PI
Aspects of Cadherin/Catenin Complexes$356,843
R01 · FY2008 · GM · contact PI
P-2: Inhibitors of N-cahedrin in the treatment of pancreatic cancer$140,122
P50 · FY2008 · CA · contact PI
Cadherins in Oral Squamous Cell Carcinomas$348,456
R01 · FY2007 · DE · contact PI
Cadherins in Oral Squamous Cell Carcinomas$358,864
R01 · FY2006 · DE · contact PI
Cadherins in Oral Squamous Cell Carcinomas$367,500
R01 · FY2005 · DE
Cadherins in Oral Squamous Cell Carcinomas$374,965
R01 · FY2004 · DE
Cadherins in Oral Squamous Cell Carcinomas$367,500
R01 · FY2003 · DE
Cadherins in Oral Squamous Cell Carcinomas$7,465
R01 · FY2003 · DE
CADHERINS IN ORAL SQUAMOUS CELL CARCINOMAS$267,592
R01 · FY2002 · DE
CADHERINS IN ORAL SQUAMOUS CELL CARCINOMAS$41,660
R01 · FY2002 · DE
CADHERINS IN ORAL SQUAMOUS CELL CARCINOMAS$227,223
R01 · FY2001 · DE
CADHERINS IN ORAL SQUAMOUS CELL CARCINOMAS$34,858
R01 · FY2001 · DE
CADHERINS IN ORAL SQUAMOUS CELL CARCINOMAS$221,187
R01 · FY2000 · DE
CADHERINS IN ORAL SQUAMOUS CELL CARCINOMAS$26,043
R01 · FY2000 · DE